Engineered Polymer–siRNA Polyplexes Provide Effective Treatment of Lung Inflammation

Citations Over TimeTop 10% of 2023 papers

Abstract

Uncontrolled inflammation is responsible for acute and chronic diseases in the lung. Regulating expression of pro-inflammatory genes in pulmonary tissue using small interfering RNA (siRNA) is a promising approach to combatting respiratory diseases. However, siRNA therapeutics are generally hindered at the cellular level by endosomal entrapment of delivered cargo and at the organismal level by inefficient localization in pulmonary tissue. Here we report efficient anti-inflammatory activity in vitro and in vivo using polyplexes of siRNA and an engineered cationic polymer (PONI-Guan). PONI-Guan/siRNA polyplexes efficiently deliver siRNA cargo to the cytosol for highly efficient gene knockdown. Significantly, these polyplexes exhibit inherent targeting to inflamed lung tissue following intravenous administration in vivo. This strategy achieved effective (>70%) knockdown of gene expression in vitro and efficient (>80%) silencing of TNF-α expression in lipopolysaccharide (LPS)-challenged mice using a low (0.28 mg/kg) siRNA dosage.

Related Papers

• → A transgenic approach for RNA interference-based genetic screening in mice(2006)57 cited
• → Systemic gene knockdown in Camponotus floridanus workers by feeding of dsRNA(2013)32 cited
• → AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1i(2011)14 cited
• → Efficient RNAi knockdown at 20 °C in Aedes albopictus (Diptera: Culicidae)(2024)3 cited
• → RNA Interference as a Tool for Producing Knockdown Mice(2005)1 cited